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Survival and frequency of malformations in Ptprs;Ptprf allelic series
	 Genotype	 Predicted		 Observed	ratio	(%)	 Urinary	tract	malformationsA	 Craniofacial	malformationsA
Ptprs	 Ptprf	 ratio	(%)	 E18.5	 4	weeks	 Hydroureter	 Duplex-system	 Micrognathia	 Exencephaly	 Open	eye
+/+ +/+ 6.25 5.66 9.33 0% (0/14) 0% (0/14) 0% (0/14) 0% (0/14) 0% (0/14)
+/+ +/ΔP 12.50 12.58 15.67 0% (0/29) 0% (0/29) 0% (0/29) 0% (0/29) 0% (0/29)
+/+ ΔP/ΔP 6.25 7.55 6.33 2% (1/42) 0% (0/42) 0% (0/42) 0% (0/42) 0% (0/42)
+/– +/+ 12.50 10.06 16.67 0% (0/21) 5% (1/21) 0% (0/21) 5% (1/21) 0% (0/21)
+/– +/ΔP 25.00 23.27 36.00 0% (0/43) 2% (1/43) 2% (1/43) 2% (1/43) 0% (0/43)
+/– ΔP/ΔP 12.50 16.35 12.33 0% (0/41) 0% (0/41) 7% (3/41) 0% (0/41) 0% (0/41)
–/– +/+ 6.25 6.92 2.00 0% (0/13) 0% (0/13) 0% (0/13) 0% (0/13) 0% (0/13)
–/– +/ΔP 12.50 11.95 1.67 4% (1/26) 0% (0/26) 0% (0/26) 0% (0/26) 0% (0/26)
–/– ΔP/ΔP 6.25 5.66 0.00 52% (16/31)B 13% (4/31) 45% (14/31) 23% (7/31) 23% (7/31)
Total   n = 159 n = 300
AShown in parentheses is the number of animals showing phenotype at E18.5/number of animals analyzed. BIncludes duplex-system phenotype.
research article













Craniofacial anomalies in Ptprs;Ptprf double-mutant embryos. (A–C) Gross morphological appearance of control (A) and Ptprs–/–PtprfΔP/ΔP (B and 
C) embryos at E18.5. Note the presence of micrognathia (arrow), exencephaly (arrowhead) and open eyelid (open arrowhead) in Ptprs–/–PtprfΔP/ΔP 
embryos. (D and E) Coronal sections of the face region of control (D) and Ptprs–/–PtprfΔP/ΔP (E) embryos stained by H&E. The tongue and pal-
ate of control embryos were readily distinguishable, whereas Ptprs–/–PtprfΔP/ΔP embryos showed smaller lower jaw (arrowhead) and an opened 
palate (open arrowhead) at an equivalent level of the head. (F–I) Coronal sections of the eye of control (F and H) and Ptprs–/–PtprfΔP/ΔP (G and I) 
embryos stained by H&E. In contrast to the characteristic eye morphology observed in control embryos, Ptprs–/–PtprfΔP/ΔP eyes sometimes 
showed a hyperplastic inner nuclear layer (single asterisk in G) and abnormal retrolental tissue (indicated by dotted line in I) filling the hyaloid 
cavity. (H and I) High-magnification views of the boxes in F and G. (I) In Ptprs–/–PtprfΔP/ΔP embryos, neuroretinal lamination was disorganized 
(arrows). Note the presence of pigmented cells (white arrowheads), the hyaloid artery within the retrolental tissue (double asterisk), and the lens 
degradation (black arrowhead). Scale bars: 1 mm (A–G) and 10 μm (H and I). ONL, outer nuclear layer; INL, inner nuclear layer.
Figure 2
Urogenital system anomalies in Ptprs;Ptprf double-mutant embryos. 
(A–C) Urogenital systems dissected from E18.5 embryos. (A) Normal 
control urogenital system. (B) Ptprs–/–PtprfΔP/ΔP urogenital system show-
ing severe hydroureter on the right side (asterisk) and mild hydroureter 
on the left side (arrowhead). (C) Ptprs–/–PtprfΔP/ΔP urogenital system 
harboring duplex-kidney (arrows) and duplex-hydroureter (asterisks). 
(D and E) Ventral views of the abdominal cavity at E18.5. Kidneys, 
ureters, and bladders were exposed and contrasted with methylene 
blue. Bladders were cut at midline and opened. Dotted lines outline the 
structures. (D) Normal control embryo. (E) Ptprs–/–PtprfΔP/ΔP embryo 
showing unilateral hydroureter with ureterocele. (F and G) H&E-stained 
sagittal sections of bladders at the level of the vesicoureteral junction 
at E18.5. (F) Normal control. Arrowhead indicates the ureter orifice. 
(G) Ptprs–/–PtprfΔP/ΔP embryo showing ureterocele membrane (arrow). 
Scale bars: 1 mm (A–E), 100 μm (F and G). DM, Ptprs;Ptprf double-
mutant; K(R), right kidney; K(L), left kidney; Bl, bladder; Te, testis; Uc, 
ureterocele; Ur, ureter.
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Impaired CND elimination 











































Distal ureter maturation defects in Ptprs–/–PtprfΔP/ΔP embryos. Top: Diagrams of WT E11.5–E15.5 urogen-
ital systems. (A–H) H&E-stained sagittal sections of representative control (A–D) and Ptprs–/–PtprfΔP/ΔP 
urogenital systems (E–H) at different developmental stages. At E11.5, no difference in CND length 
was observed between control (A) and Ptprs–/–PtprfΔP/ΔP embryos (E). CND length is indicated by dot-
ted lines, distal ureter is indicated by solid lines. At E13.5 (B and F) and E14.5 (C and G), the distal 
ureter was in close apposition with the bladder epithelium in control embryos (B and C). In contrast, 
Ptprs–/–PtprfΔP/ΔP embryos harbored a distal ureter located away from the bladder (F and G). (D and H) 
At E15.5, distal ureter elimination allowed the ureter to reconnect into bladder (dotted white circle) in a 
normal control (D), while the distal ureter remained at a distance from the bladder epithelium in Ptprs–/– 
PtprfΔP/ΔP embryos (H). (I) Length of CNDs was quantified at different developmental stages. Although 
there was no difference in CND lengths at E11.5, the CND was significantly longer in Ptprs–/–PtprfΔP/ΔP 
at E12.5 and E13.5. Error bars indicate SEM. (J–M) In situ hybridization on E12.5 transversal sections 
using antisense cRNA probes against Ptprf (J), Ptprs (K), Ptprd (L), and a sense probe against Ptprs 
(M). (J) Ptprf expression was mostly restricted to the CND, while Ptprs expression was detected ubiq-
uitously in the mesenchyme and cloaca epithelium (K). (L) Ptprd was predominantly expressed in the 
mesenchyme. (M) A sense Ptprs probe was used as negative control. Scale bars: 10 μm. ND, nephric 
duct; dUr, distal ureter; CE, cloaca epithelium.
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Apoptotic cell death in CND. (A) Schematic representation of sagittal view of a urogenital system at E12.5. Dotted lines indicate the position of 
sections shown in B–G. (B–G) TUNEL stain (red) and anti-Pax2 counterstain (green) on transverse sections of E12.5 embryos derived from 
control (B–D) and Ptprs–/–PtprfΔP/ΔP embryos (E–G). CNDs were separated into 3 sections: rostral CND (closest to ureter), middle CND, and 
caudal CND (closest to bladder). (H) Schematic representation of sagittal view of normal urogenital system at E14.0. (I and J) TUNEL stain (red) 
and anti-Pax2 counterstain (green) on sagittal sections of E14.0 control (I) and Ptprs–/–PtprfΔP/ΔP (J) urogenital systems. Dotted lines outline the 
cloaca epithelium. (K–M) Quantitative analysis of the cell death observed in control and Ptprs–/–PtprfΔP/ΔP CNDs. (K) Control embryos showed a 
strong increase in apoptosis along the rostrocaudal axis of the CND (TUNEL-positive/Pax-2–positive; n = 8 CNDs). In contrast, Ptprs–/–PtprfΔP/ΔP 
embryos showed a reduction in apoptotic cell death (n = 8 CNDs). (L) Quantitative analysis of caspase-3–positive cells showed a reduction in 
activated caspase-3–positive signals in the middle and caudal CND of Ptprs–/–PtprfΔP/ΔP embryos (n = 4 CNDs for each genotype). (M) Quantita-
tive analysis of activated caspase-8–positive cells. No significant difference was detected between control and Ptprs–/–PtprfΔP/ΔP embryos (n = 6 
CNDs for each genotype). Scale bars: 10 μm. The results shown are means ± SD.
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Molecular interaction between RPTPσ and Ret. (A) RPTPσ and 
Ret expression vectors were cotransfected in HEK293T cells and 
treated with or without GDNF/GFRα1. Top: Cell lysates were 
immunoprecipitated with anti-RPTPσ antibodies and resolved 
by SDS-PAGE, followed by immunoblotting with an anti-Ret 
antibody. The same membrane was re-blotted with anti-RPTPσ 
antibody. Ret proteins were specifically co-immunoprecipitated 
with RPTPσ-WT and RPTPσ-D/A. Bottom: Total cell lysates were 
immunoblotted with the indicated antibodies. Phosphorylation 
levels of Ret and its downstream signaling components were sig-
nificantly reduced when Ret was cotransfected with RPTPσ-WT 
or RPTPσ-D/A. (B) Flow cytometric analysis of annexin V–PE 
staining. Cells were sorted for GFP-positive signaling. The per-
centage of annexin V–PE–positive cells was increased in RPTPσ-
WT. This effect was suppressed by Ret coexpression. The results 
shown are means ± SD from 3 independent experiments.
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Immunohistochemical analysis on Ret phosphorylation. (A–E) Immunohistochemical analysis of lower urinary tracts with anti–Ret (pY1015) 
(green) (A and B), anti-Ret (green) (D and E), anti–E-cadherin (red) (A, B, D, and E), and no primary antibodies (C). Nuclei are stained with DAPI 
(blue). Green channel images from white line squares are presented in the upper right corners. (F) Quantification of immunofluorescent signals 
in E12.5 CND. Ret (pY1015) was significantly hyperphosphorylated in Ptprs–/–PtprfΔP/ΔP CNDs (B and F) in comparison with control CNDs (A). 
Note that there were no significant differences in Ret or E-cadherin expression levels between control and Ptprs–/–PtprfΔP/ΔP CND (F). Dotted 
lines outline the cloaca epithelium. (G and H) In situ hybridization analysis of E12.5 transversal sections with antisense Ret cRNA probes. Ret 
expression was present in the nephric duct but strongly downregulated in both control (G) and Ptprs–/–PtprfΔP/ΔP (H) CNDs. Scale bars: 10 μm. 
The results shown are means ± SEM. Ab (–), no primary antibody.
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Model of distal ureter rearrangement. At E11.5, a segment of the nephric duct (green) that lies between the ureteric bud site (red) and the cloaca 
(blue) is defined as the CND. At E12.5, this structure undergoes apoptosis, which allows the descent of the distal end of the ureter toward the 
bladder epithelium. At E13.5–E14, the distal ureter has completely laid down against the bladder epithelium and undergoes apoptosis. This 
causes the separation of the ureter from the nephric duct. At E14.5, these 2 structures are now separated and the ureter forms an orifice in 
the bladder epithelium, while the nephric duct drains into the urethra. Subsequent growth of the bladder allows for further separation of the 2 
orifices. In E12.5 Ptprs;Ptprf double-mutant embryos, the CND undergoes insufficient apoptosis to eliminate the structure in a timely fashion, 
thus affecting the process of distal ureter rearrangement. The initiation of urine production around E15.5–E16.5 pressures the distal end of the 
ureter, which leads to ureterocele formation.
research article


























































































































































































































































Quantification of immunofluorescent signals in the CND. Urogenital sys-
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Expression  of  the  c-ret  proto-oncogene  during 
mouse embryogenesis. Development. 119:1005–1017.
